Cell and cytokine imbalances in rheumatoid synovitis

Joint Bone Spine

Volumn 78, Issue 3, 2011, Pages 230-234

  Boissier, Marie Christophe ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Autoimmunity; Cytokines; Rheumatoid arthritis; T cells; Tissue damage

Indexed keywords

EPITOPE; HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 22; INTERLEUKIN 33; INTERLEUKIN 6; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR; WNT PROTEIN;

ALLELE; B LYMPHOCYTE; CARTILAGE DEGENERATION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE DYSREGULATION; JOINT DESTRUCTION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; OSTEOCLAST; PHENOTYPE; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SHORT SURVEY; SMOKING; SYNOVITIS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; JOINTS; RISK FACTORS; SELF TOLERANCE; SMOKING; SYNOVITIS; T-LYMPHOCYTES;

EID: 79955528848     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.08.017     Document Type: Short Survey

References (35)

1. Silman A.J., MacGregor A.J., Thomson W., et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 1993, 32:903-907.
2. Goronzy J.J., Weyand C.M. Developments on the scientific understanding of rheumatoid arthritis. Arthritis Res Ther 2009, 11:249.
3. Bottini N., Vang T., Cucca F., et al. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006, 18:207-213.
4. Dieudé P. Rheumatic diseases: environnement and genetics. Joint Bone Spine 2009, 76:602-607.
5. Klareskog L., Stolt P., Lundberg K., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38-46.
6. Auger I., Balandraud N., Rak J., et al. New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann Rheum Dis 2009, 68:591-594.
7. Fuji H., Shao L., Colmegna I., et al. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A 2009, 106:4360-4365.
8. Rantapaa-Dahlqvist A., de Jong B.A., Berglin E., et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749.
9. Karlson E.W., Chibnik L.B., Tworoger S.S., et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 2009, 60:641-652.
10. Weyand C.M., Kurtin P.J., Goronzy J.J. Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am J Pathol 2001, 159:787-793.
11. Zhang Z., Gorman C.L., Vermi A.C., et al. TCR zetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues. Blood 2007, 109:4328-4335.
12. Bessis N., Guéry L., Mantovani A., et al. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur J Immunol 2000, 30:867-875.
13. Chizzolini C., Dayer J.M., Miossec P. Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?. Arthritis Res Ther 2009, 11:246.
14. Assier E., Boissier M.C., Dayer J.M. Interleukin-6: from identification of the cytokine to development of targeted treatments. Joint Bone Spine 2010, (in press). 10.1016/j.jbspin.2010.07.007.
15. Knupfer H., Preiss R. sIL-6R: more than an agonist?. Immunol Cell Biol 2008, 86:87-91.
16. Arend W.P., Palmer G., Gabay C. IL-1, IL-18 and IL-33 families of cytokines. Immunol Rev 2008, 223:20-38.
17. Gabay C., McInnes I.B. The biological and clinical importance of the " new generation" cytokines in rheumatic diseases. Arthritis Res Ther 2009, 11:230.
18. Kim S.H., Han S.Y., Yoon D.Y., et al. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22:131-142.
19. Dubois S., Mariner J., Waldmann T.A., et al. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 2002, 17:537-547.
20. Palmer G., Talabot-Ayer D., Lamacchia C., et al. Inhibition of interleukine-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 2009, 60:738-749.
21. Boissier M.C., Assier E., Falgarone G., et al. Shifting the imbalance from Th1/Th2 to Th17/Treg: the changing rheumatoid arthritis paradigm. Joint Bone Spine 2008, 75:375-1375.
22. Boissier M.C., Chiocchia G., Bessis N., et al. Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immmunol 1995, 25:1184-1190.
23. Boissier M.C., Assier E., Biton J., et al. Regulatory Tcells (Treg) in rheumatoid arthritis. Joint Bone Spine 2009, 76:10-14.
24. Steinman L. Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nature Immunol 2010, 11:41-44.
25. Duvallet E., Ratsimandresy R., Assier E., et al. Active immunization against IL-23p19 improves collagen-induced arthritis. Arthritis Rheum 2009, 60:S1-S2. [abs].
26. Semerano L., Boissier M.C. Monoclonal antibodies in chronic autoimmune inflammatory diseases. Med Sci (Paris) 2009, 25:1108-1112.
27. Bettelli E., Carrier Y., Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
28. Wing K., Sakaguchi S., Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nature Immunol 2010, 11:7-13.
29. Collison L.W., Workman C.J., Kuo T.T., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
30. Fitzgerald D.C., Rostami A. Therapeutic potential of IL-27 in multiple sclerosis?. Expert Opin Biol Ther 2009, 9:149-160.
31. Rezzonico R., Burger D., Dayer J.M. Direct contact between T lymphocytes and human dermal fibroblasts or synoviocytes down-regulate type I and type III collagen production via cell-associated cytokines. J Biol Chem 1998, 273:18720-18728.
32. Burger D., Dayer J.M. The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res 2002, 2(Suppl. 3):S169-S176.
33. Chabaud M., Aarvak T., Garnero P., et al. Potential contribution of IL-17 producing Th(1) cells to defective repair activity in joint inflammation: partial correction with Th(2)-promoting conditions. Cytokine 2001, 13:113-118.
34. Polzer K., Diarra D., Zwerina J., et al. Inflammation and destruction of the joints-The Wnt pathway. Joint Bone Spine 2008, 75:105-107.
35. Saidenberg-Kermanac'h N., Corrado A., Lemeiter D., et al. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 2004, 35:1200-1207.